Vanguard Group Inc Nuvasive Inc Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $556,964 - $669,843	-15,172 Reduced 0.26%	5,918,726 $246 Million
Q1 2023 May 15, 2023	SELL	$36.81 - $48.12 $11.1 Million - $14.5 Million	-302,214 Reduced 4.85%	5,933,898 $245 Million
Q4 2022 Feb 10, 2023	BUY	$35.68 - $44.71 $29.3 Million - $36.8 Million	822,094 Added 15.18%	6,236,112 $257 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $4.27 Million - $5.43 Million	100,467 Added 1.89%	5,414,018 $237 Million
Q2 2022 Aug 12, 2022	BUY	$46.84 - $59.75 $12.5 Million - $16 Million	267,081 Added 5.29%	5,313,551 $261 Million

Q1 2022 May 13, 2022	SELL	$48.09 - $57.79 $2.41 Million - $2.89 Million	-50,085 Reduced 0.98%	5,046,470 $286 Million
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $4.53 Million - $6.01 Million	95,952 Added 1.92%	5,096,555 $267 Million
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $2.17 Million - $2.59 Million	38,186 Added 0.77%	5,000,603 $299 Million
Q2 2021 Aug 13, 2021	BUY	$64.02 - $71.72 $318 Million - $356 Million	4,962,417 New	4,962,417 $336 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.